Global Clinical Nutrition Market 2018-2022

Detailed TOC of Global Clinical Nutrition Market 2018-2022

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: MARKET LANDSCAPE 
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING 
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS 
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: SEGMENTATION BY ROA 
• Overview
• Comparison by RoA
• Enteral nutrition
• Parenteral nutrition
• Market opportunity by RoA
PART 08: CUSTOMER LANDSCAPE 
PART 09: REGIONAL LANDSCAPE 
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK 
PART 11: DRIVERS AND CHALLENGES 
• Market drivers
• Market challenges
PART 12: MARKET TRENDS 
• Online retailing
• Increasing number of nutritionists and food consultants
• Growing adoption of ready-to-use nutritional supplements
PART 13: VENDOR LANDSCAPE 
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS 
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Baxter
• B. Braun Melsungen
• GlaxoSmithKline
• Fresenius
• Nestlé
PART 15: APPENDIX 
• List of abbreviations 

Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Global clinical nutrition market: Segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global clinical nutrition market 2017-2022 ($ billions)
Exhibit 08: Global clinical nutrition market: Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition: Five forces 2017
Exhibit 17: Global clinical nutrition market: Segmentation by RoA 2017-2022 (% share)
Exhibit 18: Comparison by RoA
Exhibit 19: Global enteral clinical nutrition market 2017-2022 ($ billions)
Exhibit 20: Global enteral clinical nutrition market: Year-over-year growth 2018-2022 (%)
Exhibit 21: Global parenteral clinical nutrition market 2017-2022 ($ billions)
Exhibit 22: Global parenteral clinical nutrition market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Market opportunity by RoA
Exhibit 24: Customer landscape
Exhibit 25: Global clinical nutrition market: Segmentation by geography 2017-2022 (% share)
Exhibit 26: Regional comparison
Exhibit 27: Clinical nutrition market in Americas 2017-2022 ($ billions)
Exhibit 28: Clinical nutrition market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 29: Clinical nutrition market in EMEA 2017-2022 ($ billions)
Exhibit 30: Clinical nutrition market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 31: Clinical nutrition market in APAC 2017-2022 ($ billions)
Exhibit 32: Clinical nutrition market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Population aged 65 and above (% share)
Exhibit 36: Countries with high premature births 2016
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Abbott: Overview
Exhibit 43: Abbott: Business segments
Exhibit 44: Abbott: Organizational developments
Exhibit 45: Abbott: Geographic focus
Exhibit 46: Abbott: Segment focus
Exhibit 47: Abbott: Key offerings
Exhibit 48: Baxter: Overview
Exhibit 49: Baxter: Business segments
Exhibit 50: Baxter: Organizational developments
Exhibit 51: Baxter: Geographic focus
Exhibit 52: Baxter: Segment focus
Exhibit 53: Baxter: Key offerings
Exhibit 54: B. Braun Melsungen: Overview
Exhibit 55: B. Braun Melsungen: Business segments
Exhibit 56: B. Braun Melsungen: Organizational developments
Exhibit 57: B. Braun Melsungen: Geographic focus
Exhibit 58: B. Braun Melsungen: Segment focus
Exhibit 59: B. Braun Melsungen: Key offerings
Exhibit 60: GlaxoSmithKline: Overview
Exhibit 61: GlaxoSmithKline: Business segments
Exhibit 62: GlaxoSmithKline: Organizational developments
Exhibit 63: GlaxoSmithKline: Geographic focus
Exhibit 64: GlaxoSmithKline: Segment focus
Exhibit 65: GlaxoSmithKline: Key offerings
Exhibit 66: Fresenius: Overview
Exhibit 67: Fresenius: Business segments
Exhibit 68: Fresenius: Organizational developments
Exhibit 69: Fresenius: Geographic focus
Exhibit 70: Fresenius: Segment focus
Exhibit 71: Fresenius: Key offerings
Exhibit 72: Nestlé: Overview
Exhibit 73: Nestlé: Business segments
Exhibit 74: Nestlé: Organizational developments
Exhibit 75: Nestlé: Geographic focus
Exhibit 76: Nestlé: Segment focus
Exhibit 77: Nestlé: Key offerings